此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter

2019年8月19日 更新者:Danielle McCarthy、Northwestern University
The investigators overall study objective is to improve patients knowledge and safe use of opioid pain relievers upon discharge from the Emergency Department.

研究概览

详细说明

Recent studies indicate that emergency department (ED) discharge processes - including written and spoken communications - are inadequate, and patients often leave without the knowledge necessary to properly care for themselves. In the context of opioid pain relievers, this lack of knowledge is potentially dangerous, as patients may not possess the requisite knowledge for safe use of their medication or an awareness of the dangers of medication misuse.

The aim of this study was to evaluate the impact of an opioid information sheet and spoken counseling on patient knowledge about opioids and safe use behaviors. The investigators conducted a randomized controlled pilot test of a dual-modality educational intervention (written information sheet and spoken counseling about opioids) to assess if the intervention can increase patient knowledge about opioid pain relievers. These activities were intended to guide future modification of educational interventions and the future development of best practices for emergency physician spoken counseling about opioid pain relievers.

研究类型

介入性

注册 (实际的)

278

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Illinois
      • Chicago、Illinois、美国、60611
        • Northwestern University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • prescribed an opioid pain reliever
  • English Speaking

Exclusion Criteria:

  • Non-English Speaking
  • Clinically unstable, psychologically impaired or intoxicated as judged by the research staff member.
  • Chronic opioid use, defined as daily or near daily use of opioid pain relievers for the past 90 days.
  • admitted to hospital
  • unable to complete follow up phone interview in 4 - 7 days.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:Control
Patients in this arm are discharged from the Northwestern Emergency Department with standard communication about their prescribed opioid pain medication from their care providers. They are called for a follow up survey 4-7 days after their visit.
实验性的:Dual Modality Educational Intervention
Patients in this arm are discharged from the ED with an additional information sheet about their prescribed opioid pain medication, via the intervention titled "Additional Opioid Information". The sheet is read aloud to them by a research assistant. They are called 4-7 days later for a follow up survey.
Patients receiving this intervention are given additional information about the opioid pain medication that they are receiving in the form of a one page handout. The hand out was written in a health-literacy appropriate manner. A research assistant read the handout to them out loud, and they were given a copy to take home with them.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Knowledge of medication name
大体时间:4-7 days
The primary outcome was the patients ability to identify the medication name of their prescribed opioid pain reliever upon follow-up.
4-7 days

次要结果测量

结果测量
措施说明
大体时间
Knowledge and counseling recall outcomes
大体时间:4-7 days
In addition to the outcome of medication name patients were asked additional knowledge and recall questions including: active ingredients in the medication, knowledge about safe daily dose of acetaminophen, side effects, recall of counseling about activities to avoid (drinking alcohol, driving vehicle), knowledge about addictive potential of the medication.
4-7 days
Actual Use outcomes
大体时间:4-7 days
Patients were queried about their home use of the medication including: pain score at home, average number of tabs per day, and satisfaction with pain reduction. Additionally they were asked about the timing of any alcohol consumption or driving in relation to the timing of medication dosing.
4-7 days
Response to the intervention
大体时间:4-7 days
Patients in the intervention arm were asked how they liked the intervention using a series of question with a Likert scale.
4-7 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Danielle McCarthy, MD MS、Northwestern University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2012年10月1日

初级完成 (实际的)

2013年5月1日

研究完成 (实际的)

2013年5月1日

研究注册日期

首次提交

2014年11月20日

首先提交符合 QC 标准的

2014年11月21日

首次发布 (估计)

2014年11月24日

研究记录更新

最后更新发布 (实际的)

2019年8月20日

上次提交的符合 QC 标准的更新

2019年8月19日

最后验证

2019年8月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Additional Opioid Information的临床试验

3
订阅